Skip to main content

Table 1 Clinical characteristics of patients with KPC-2-NDM-1-CR-hvKP

From: Genomic insights into the evolution and mechanisms of carbapenem-resistant hypervirulent Klebsiella pneumoniae co-harboring blaKPC and blaNDM: implications for public health threat mitigation

Variables/patients

Patient 1

Patient 2

Patient 3

Patient 4

Patient 5

Strain

JNKPN23

JNKPN24

JNKPN26

JNKPN29

JNKPN31

Clinical characteristics

 Age

70

70

44

56

69

 Gender

Female

Female

Female

Female

Female

 City

JINAN

JINAN

JINAN

JINAN

JINAN

 Ward

ICU

ICU

ICU

ICU

ICU

 Underlying conditions

Right oophorectomy, myocardial ischemia, chronic ischemic heart disease, respiratory failure

Hypertension, diabetes, dyslipidemia

Hepatic cyst, splenic cyst

Esophageal squamous cell carcinoma

Hypertension, diabetes, UTI

Invasive procedures

 Mechanical ventilation

Yes

Yes

Yes

Yes

Yes

 Drainage catheters

Yes

Yes

Yes

Yes

Yes

 Surgery

Yes

Yes

Yes

Yes

Yes

 Date of specimen collection

2019/2/5

2019/2/15

2019/2/28

2019/3/6

2019/3/15

 Infection type

Severe pneumonia, sepsis

Severe pneumonia, sepsis

Severe pneumonia

Severe pneumonia

Severe pneumonia

 Prior antibiotic usage within 30 days

Yes

Yes

Yes

Yes

Yes

 Empirical antimicrobial usage

CSL + POL + TZP + TGC

TZP + TGC

CSL + TZP + CIP + LZD + POL + ETS

CXM + CSL + ETS + LZD + MIN

ETS + TZP + LEV

Clinical presentations

 Temperature (max °C)

39.2 °C

38.6 °C

39.5 °C

39.1 °C

38.2 °C

 WBC (×109/L)

27.83

29.49

28.73

20.93

16.04

 Therapeutic antimicrobial usage

TOB + IPM + TGC

TZP + TGC + POL

LZD + POL + MEM + LEV + TZP + ETS

LZD + MIN

LEV

Clinical outcomes

 Days of mechanical ventilation

6

12

51

10

7

 Duration of ICU stay (days)

6

12

56

29

30

 Outcome

Death

Death

Survived

Death

Survived

  1. CSL cefoperazone/sulbactam, POL polymyxin, TZP piperacillin/tazobactam, IPM/CS imipenem/cilastatin, TOB tobramycin, TGC tigecycline, LZD linezolid, CIP ciprofloxacin, MEM meropenem, LEV levofloxacin, CXM cefuroxime sodium, MIN minocycline, ETS etimicin sulfate, UTI urinary tract infection